title: [Demyelinating diseases in children with acute neurological symptoms].
abstract: Demyelinating diseases in children is a broad group of illnesses, which affect the central nervous system. Demyelinating diseases can be monophasic or chronic and comprise acute disseminated encephalomyelitis, optic neuritis, transverse myelitis, multiple sclerosis and neuromyelitis optica. Demyelinating diseases are rare, but it is important for the physician to recognize these diseases, as well as to understand the differential diagnoses. This review summarizes the current knowledge of demyelinating disorders in children, focusing on an approach to diagnosis and management.
authors.affiliation: olofsson.isa@gmail.com.
authors.forename: Isa Amalie
authors.initials: IA
authors.lastname: Olofsson
authors.forename: Liselotte
authors.initials: L
authors.lastname: Skov
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Miranda
mesh_terms: D002648:Child; D002675:Child, Preschool; D003711:Demyelinating Diseases / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D004673:Encephalomyelitis, Acute Disseminated / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy; D009188:Myelitis, Transverse / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy; D009471:Neuromyelitis Optica / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D009902:Optic Neuritis / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D018696:Neuroprotective Agents; D008775:Methylprednisolone